Abstract
“The advent of high-throughput techniques for the study of thewhole miRNome (defined as the full spectrum of miRNAs in a genome) in one biologic sample, has allowed the detection of specific signatures of deregulated miRNAs in cancer versus normal tissues, with diagnostic and sometime prognostic implications.”
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.